Sign In
Buy SDGR
$15.14
-0.210 (-1.37%)
At Close: Jul 31, 2026
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
07:30am, Monday, 27'th Jul 2026
NEW YORK--(BUSINESS WIRE)---- $SDGR #BunsenAI--Schrödinger, Inc. today announced the launch of its early access version of Bunsen, its new agentic AI co-scientist.
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
09:05am, Thursday, 23'rd Jul 2026
/PRNewswire/ -- For years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5
08:30am, Wednesday, 22'nd Jul 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the financial markets close. The company will hos
Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc.
03:16am, Tuesday, 21'st Jul 2026
Amova Asset Management Americas Inc. boosted its holdings in shares of Schrodinger, Inc. (NASDAQ: SDGR) by 13.2% in the first quarter, according to its most recent disclosure with the Securities and E
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Monday, 20'th Jul 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on July 16, 2026, the company granted restricted stock units (RSUs) with respect to 3,691 shares of the company's commo
AMD Is Up 150% This Year But Here Are 5 Overlooked Stocks Betting on What Comes Next
12:16pm, Wednesday, 01'st Jul 2026
The Pentagon just earmarked over $74 billion for drone dominance and counter drone technologies in the FY2027 budget request, and that is only one slice of the AI arms race AMD and NVIDIA are fighting
A Look at Schrodinger Inc (SDGR) After 6.6% Decline -- GF Value $26.32 vs Price $16.25
09:36pm, Tuesday, 30'th Jun 2026
On June 30, 2026, Schrodinger Inc (SDGR) shares fell 6.6% today, bringing the current price to $16.25. Over the past 52 weeks, shares have traded as high as $23
AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity
09:38am, Tuesday, 30'th Jun 2026
Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from Silicon Valley. Biotechnology has spent decades producing breakthrough medicines
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
09:00am, Thursday, 18'th Jun 2026
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 12, 2026, the company granted restricted stock units (RSUs) with respect to 10,771 shares of the
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Thursday, 18'th Jun 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 12, 2026, the company granted restricted stock units (RSUs) with respect to 10,771 shares of the company's comm
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
05:12pm, Tuesday, 02'nd Jun 2026
Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash flow, and valuation.
A Look at Schrodinger Inc (SDGR) After 6.9% Gain -- GF Value $26.55 vs Price $14.15
09:15pm, Thursday, 28'th May 2026
On May 28, 2026, Schrodinger Inc (SDGR) shares rose 6.9% to a current price of $14.15. The stock has experienced considerable volatility, with a 52-week range b
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Friday, 22'nd May 2026
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on May 18, 2026, the company granted (i) a non-statutory stock option to purchase 1,875 shares of the company's common
My Top 3 Biotech Stocks for May 2026
11:15am, Wednesday, 20'th May 2026
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.
7 Healthcare AI Stocks Under $50 With Huge Upside Potential
07:35am, Monday, 18'th May 2026
Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as their underlying platforms keep maturing.
